Literature DB >> 2070327

Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases.

J C Flickinger1, A H Epstein, S Iwatsuki, B I Carr, T E Starzl.   

Abstract

From 1976 to 1988, 63 patients received radiation therapy for primary cancers of the extrahepatic biliary system (eight gallbladder and 55 extrahepatic biliary duct). Twelve patients underwent orthotopic liver transplantation. Chemotherapy was administered to 13 patients. Three patients underwent intraluminal brachytherapy alone (range, 28 to 55 Gy). Sixty patients received megavoltage external-beam radiation therapy (range, 5.4 to 61.6 Gy; median, 45 Gy), of whom nine received additional intraluminal brachytherapy (range, 14 to 45 Gy; median, 30 Gy). The median survival of all patients was 7 months. Sixty patients died, all within 39 months of radiation therapy. One patient is alive 11 months after irradiation without surgical resection, and two are alive 50 months after liver transplantation and irradiation. Symptomatic duodenal ulcers developed after radiation therapy in seven patients but were not significantly related to any clinical variable tested. Extrahepatic biliary duct cancers, the absence of metastases, increasing calendar year of treatment, and liver transplantation with postoperative radiation therapy were factors significantly associated with improved survival.

Entities:  

Mesh:

Year:  1991        PMID: 2070327      PMCID: PMC2975608          DOI: 10.1002/1097-0142(19910715)68:2<289::aid-cncr2820680213>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  44 in total

1.  Primary and adjuvant radiation therapy in gallbladder and extrahepatic biliary tract carcinoma.

Authors:  G Kopelson; L L Gunderson
Journal:  J Clin Gastroenterol       Date:  1983-02       Impact factor: 3.062

2.  Diagnosis and treatment of primary extrahepatic bile duct tumors.

Authors:  W R Chitwood; W C Meyers; D K Heaston; A M Herskovic; M E McLeod; R S Jones
Journal:  Am J Surg       Date:  1982-01       Impact factor: 2.565

3.  Prognostic factors in bile duct carcinoma: analysis of 96 cases.

Authors:  R K Tompkins; D Thomas; A Wile; W P Longmire
Journal:  Ann Surg       Date:  1981-10       Impact factor: 12.969

4.  Carcinoma of the bile ducts.

Authors:  C D Lees; A Zapolanski; A M Cooperman; R E Hermann
Journal:  Surg Gynecol Obstet       Date:  1980-08

5.  Proximal bile duct tumors: surgical management with silastic transhepatic biliary stents.

Authors:  J L Cameron; P Broe; G D Zuidema
Journal:  Ann Surg       Date:  1982-10       Impact factor: 12.969

6.  Carcinoma of the bifurcation of the hepatic ducts.

Authors:  T Tsuzuki; Y Ogata; S Iida; I Nakanishi; Y Takenaka; H Yoshii
Journal:  Arch Surg       Date:  1983-10

7.  A new method for treating carcinomatous biliary obstruction with intracatheter radium.

Authors:  R M Conroy; A A Shahbazian; K C Edwards; E M Moran; K F Swingle; G J Lewis; H F Pribram
Journal:  Cancer       Date:  1982-04-01       Impact factor: 6.860

8.  Role of liver transplantation in cancer therapy.

Authors:  S Iwatsuki; R D Gordon; B W Shaw; T E Starzl
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

9.  Treatment of hilar carcinoma by bile drainage combined with internal radiotherapy using 192iridium wire.

Authors:  M S Fletcher; D Brinkley; J L Dawson; H Nunnerley; R Williams
Journal:  Br J Surg       Date:  1983-12       Impact factor: 6.939

10.  Radiation therapy of carcinoma of the extrahepatic bile ducts.

Authors:  Y Hishikawa; T Shimada; T Miura; Y Imajyo
Journal:  Radiology       Date:  1983-03       Impact factor: 11.105

View more
  12 in total

1.  Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.

Authors:  J Devlin; J O'Grady
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

2.  Antitumor effect of the paclitaxel-eluting membrane in a mouse model.

Authors:  Jin-Seok Park; Seok Jeong; Don Haeng Lee; Jin Hee Maeng; In Suh Park; Sangsoo Park
Journal:  Oncol Lett       Date:  2018-07-17       Impact factor: 2.967

3.  Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder.

Authors:  Hiroshi Itoh; Koji Nishijima; Yoshiyuki Kurosaka; Shigeru Takegawa; Masato Kiriyama; Shotaro Dohba; Yasuhiko Kojima; Yasuo Saitoh
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

4.  Diagnosis, Staging, and Treatment of Cholangiocarcinoma.

Authors:  Jung-Hwan Yoon; Gregory J. Gores
Journal:  Curr Treat Options Gastroenterol       Date:  2003-04

Review 5.  Liver transplantation for cholangiocarcinoma: Current status and new insights.

Authors:  Gonzalo Sapisochín; Elena Fernández de Sevilla; Juan Echeverri; Ramón Charco
Journal:  World J Hepatol       Date:  2015-10-08

Review 6.  Positioning high-dose radiation in multidisciplinary management of unresectable cholangiocarcinomas: review of current evidence.

Authors:  Supriya Chopra; Ashwathy S Mathew; Reena Engineer; Shyam K Shrivastava
Journal:  Indian J Gastroenterol       Date:  2014-08-20

7.  Adjuvant radiotherapy for gallbladder cancer: a dosimetric comparison of conformal radiotherapy and intensity-modulated radiotherapy.

Authors:  Xiao-Nan Sun; Qi Wang; Ben-Xing Gu; Yan-Hong Zhu; Jian-Bin Hu; Guo-Zhi Shi; Shu Zheng
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

8.  Comparison of external beam radiation and brachytherapy to external beam radiation alone for unresectable extrahepatic cholangiocarcinoma.

Authors:  Dustin Boothe; Zachary Hopkins; Jonathan Frandsen; Shane Lloyd
Journal:  J Gastrointest Oncol       Date:  2016-08

9.  New advances in the management of biliary tract cancer.

Authors:  John Bridgewater; Charles Imber
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

10.  Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival.

Authors:  H A Pitt; A Nakeeb; R A Abrams; J Coleman; S Piantadosi; C J Yeo; K D Lillemore; J L Cameron
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.